key: cord-0749665-w2rgunms
authors: Ganguly, Shuvadeep; Bakhshi, Sameer
title: Traditional and complementary medicine during COVID‐19 pandemic
date: 2020-08-12
journal: Phytother Res
DOI: 10.1002/ptr.6828
sha: 4331c27c6c87a05819a1f46996595948a50ea603
doc_id: 749665
cord_uid: w2rgunms

nan

The recent corona virus disease-19 (COVID-19) pandemic has uniquely challenged medical research community worldwide due to absence of any vaccine or proven therapy. Repurposing of already available drugs is a prudent strategy for immediate management of those severely affected by the disease. To that end, clinical interventional studies are being conducted with multitude of drugs ranging from seemingly innocuous like zinc to potentially toxic drugs. Traditional and complementary medicine (T&CM) especially traditional herbal medicines, however, find little mention in mainstream discourse of COVID-19 pandemic.

A comprehensive search of four prominent clinical trial registers ( (8), nivolumab (5), pembrolizumab (1), selinexor (3), bevacizumab (5), acalabrutinib (4),

Advisory from Ministry of AYUSH for meeting the challenge arising out of spread of corona virus (Covid-19) in India

A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies: Efficacy and safety of herbal remedies

Efficacy and safety of integrated traditional Chinese and Western medicine for Corona virus disease 2019 (COVID-19): A systematic review and meta-analysis

Broad-spectrum antivirals against viral fusion

WHO global report on traditional and complementary medicine. Geneva: World Health Organization

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study